Family trust plans sale of 262,388 shares

A family trust has filed a notice of proposed sale under Rule 144 to sell 262,388 shares of Class A Common Stock through Merrill Lynch on the NYSE, with an approximate sale date of 01/21/2026.

Rhea-AI Filing Summary

A family trust has filed a notice of proposed sale under Rule 144 to sell 262,388 shares of Class A Common Stock through Merrill Lynch on the NYSE, with an approximate sale date of 01/21/2026. The aggregate market value of the planned sale is listed as 5518019.64, while 238,040,782 shares of this class were outstanding at the time indicated. The securities were acquired on 02/17/2020 via estate planning transfers from the settlor of the trust, whose accounts are the source of the shares. The trust also sold 50,105 shares of Class A Common Stock in the past three months on 12/26/2025, generating gross proceeds of 999093.7.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing mean for ZETA investors?

This Form 144 shows that a family trust intends to sell 262,388 shares of Class A Common Stock on the NYSE under Rule 144. It is a disclosure of a planned sale by an existing holder, not an issuance of new shares by ZETA.

How many ZETA shares is the trust planning to sell under this Form 144?

The trust plans to sell 262,388 shares of ZETA Class A Common Stock, with an aggregate market value listed as 5518019.64.

How many ZETA Class A shares were outstanding compared to this planned sale?

The filing states that 238,040,782 shares of Class A Common Stock were outstanding, compared with the 262,388 shares covered by this planned sale.

When were the ZETA shares being sold originally acquired by the trust?

The Class A Common Stock being sold was acquired on 02/17/2020 through estate planning transfers from the settlor of the trust, who originally acquired the securities on 01/01/2015.

Has the same trust recently sold other ZETA shares?

Yes. Over the past three months, the family trust sold 50,105 shares of Class A Common Stock on 12/26/2025, receiving gross proceeds of 999093.7.

On which exchange and through which broker are the ZETA shares planned to be sold?

The filing lists Merrill Lynch as the broker, with the Class A Common Stock planned to be sold on the NYSE from an address at 200 Park Ave, New York, NY 10166.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/16/2026 - 04:59 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001989510
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Zeta Global Holdings Corp
SEC File Number	001-40464
Address of Issuer	3 Park Avenue 33rd Floor New York NEW YORK 10016
Phone	212-967-5055
Name of Person for Whose Account the Securities are To Be Sold	Family Trust No C5
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Merrill Lynch 200 Park Ave New York NY 10166	262388	5518019.64	238040782	01/21/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	02/17/2020	Estate Planning Transfers	Acquired from the settlor of the trust for whose accounts the securites are being sold		01/01/2015	262388	02/17/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Family Trust No C5 42 Beacon Hill Lane New Canaan CT 06840	Class A Common Stock	12/26/2025	50105	999093.7

144: Remarks and Signature

Remarks	Additional sales within the past 3 months included on attached trade addendum
Date of Notice	01/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Caroline Toce
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)